Hepatic Encephalopathy

被引：61

作者：

Khungar, Vandana ^{[1
,2
]}

Poordad, Fred ^{[1
,3
]}

机构：

[1] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA

[3] Cedars Sinai Med Ctr, Dept Surgey, Los Angeles, CA 90048 USA

来源：

CLINICS IN LIVER DISEASE | 2012年 / 16卷 / 02期

关键词：

Hepatic encephalopathy; Minimal hepatic encephalopathy; Overt hepatic encephalopathy; Treatment; INTRAHEPATIC PORTOSYSTEMIC SHUNT; ORNITHINE-L-ASPARTATE; PORTAL-SYSTEMIC ENCEPHALOPATHY; RANDOMIZED CONTROLLED-TRIAL; ORAL ZINC SUPPLEMENTATION; QUALITY-OF-LIFE; DOUBLE-BLIND; RIFAXIMIN TREATMENT; LIVER-CIRRHOSIS; NEUROPSYCHOLOGICAL CHARACTERIZATION;

D O I：

10.1016/j.cld.2012.03.009

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatic encephalopathy (HE) represents a continuum of transient and reversible neurologic and psychiatric dysfunction. It is a reversible state of impaired cognitive function or altered consciousness in patients with liver disease or portosystemic shunting. Over the last several years, high-quality studies have been conducted on various pharmacologic therapies for HE; as more data emerge, it is hoped that HE will become a more easily treated complication of decompensated liver disease. In the interim, it is important that physicians continue to screen for minimal HE and treat patients early in addition to continuing to provide current treatments of overt HE.

引用

页码：301 / +

页数：21

共 50 条

[21] Clinical management of type C hepatic encephalopathy
Ridola, Lorenzo
Riggio, Oliviero
Gioia, Stefania
Faccioli, Jessica
Nardelli, Silvia
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (05) : 536 - 543
[22] Pharmacotherapy for Hepatic Encephalopathy
Phongsamran, Paula V.
Kim, Jiwon W.
Abbott, Jennifer Cupo
Rosenblatt, Angela
DRUGS, 2010, 70 (09) : 1131 - 1148
[23] Hepatic encephalopathy: from pathophysiology to therapeutic management
Bismuth, Michael
Funakoshi, Natalie
Cadranel, Jean-Francois
Blanc, Pierre
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (01) : 8 - 22
[24] Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
Bellafante, Daniele
Gioia, Stefania
Faccioli, Jessica
Riggio, Oliviero
Ridola, Lorenzo
Nardelli, Silvia
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
[25] Recent insights into the pathogenesis of hepatic encephalopathy and treatments
Sturgeon, Jonathan P.
Shawcross, Debbie L.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (01) : 83 - 100
[26] Current vision on diagnosis and comprehensive care in hepatic encephalopathy
Higuera-de-la-Tijera, F.
Velasco, J. A. Velarde-Ruiz
Rana-Garibay, R. H.
Castro-Narro, G. E.
Abdo-Francis, J. M.
Moreno-Alcantar, R.
Perez-Hernandez, J. L.
Torre, A.
Contreras-Omana, R.
Cano-Contreras, A.
Castillo-Barradas, M.
Perez-Escobar, J.
Aldana-Ledesma, J. M.
Cerda-Reyes, E.
Fernandez-Perez, N. J.
Meza-Cardona, J.
Flores-Garcia, N. C.
Reyes-Bastidas, M.
Lira-Verao, J. E.
Garcia-Jimenez, E. S.
Santana-Vargas, D.
Paez-Zayasa, V. M.
Chavez-Tapia, N. C.
Marquez-Guillen, E.
REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2023, 88 (02): : 155 - 174
[27] Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Zacharias, Harry D.
Kamel, Fady
Tan, Jaclyn
Kimer, Nina
Gluud, Lise Lotte
Morgan, Marsha Y.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (07):
[28] How to Design a Multicenter Clinical Trial in Hepatic Encephalopathy
Ridola, Lorenzo
Nardelli, Silvia
Gioia, Stefania
Riggio, Oliviero
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (01) : 137 - 145
[29] Diagnosis and Management of Hepatic Encephalopathy
Rudler, Marika
Weiss, Nicolas
Bouzbib, Charlotte
Thabut, Dominique
CLINICS IN LIVER DISEASE, 2021, 25 (02) : 393 - 417
[30] Disaccharides in the treatment of hepatic encephalopathy
Sharma, Praveen
Sharma, Barjesh Chander
METABOLIC BRAIN DISEASE, 2013, 28 (02) : 313 - 320

← 1 2 3 4 5 →